// Who They Are
PhD scientist and regular Hash Church panelist with deep knowledge of cannabinoid pharmacology, FDA drug approval processes, and cannabis policy. Provided detailed analysis of Schedule 3 implications including nano emulsion technology, 280E tax reform, and the billion-dollar cost of FDA drug approval.
// Notable Quotes
" Moving a plant that people can grow themselves to schedule three is absolutely ridiculous. "
" The hypocrisy needs to become unwound that the source of these active ingredients in these FDA approved drugs are coming from this plant that you're claiming has no medical benefit. "